About Us  Contact Us  Donate                     

logo ogcc

   button donate  button share your survivor story  button volunteer

ChemoFx Improves Ovarian Cancer Outcomes

ChemoFx® provides invaluable information to physicians choosing from 20 equivalent treatment recommendations without prior knowledge of how individual ovarian cancer patients may respond. ChemoFx determines platinum resistance in primary ovarian cancer and demonstrates longer overall survival by 14 months in recurrent ovarian cancer, making it instrumental in improving patient outcomes.

Thank you to our supporters!

supporter logo flt    supporter logo ocrfa     supporter logo potomac at avenel